At ASN Kidney Week 2026, nephrologists said value-based kidney models improved dialysis starts, but payment cuts and MA growth are pushing practices out.
Feature|Articles|May 15, 2026
5 Things to Pay Attention to During Women's Health Month
Author(s)Giuliana Grossi
Fact checked by: Christina Mattina
Women’s Health Month highlights major 2026 shifts in menopause care, brain health, abortion access, doula coverage, and wearable tech.
Advertisement
Advertisement
Women's health is experiencing a watershed moment in 2026. After decades of underinvestment and overlooked research gaps, the sector is seeing unprecedented clinical innovation and policy scrutiny. From how we treat menopause to how women access abortion care, the evidence landscape is shifting rapidly. Here are 5 critical trends that every health care stakeholder should be tracking.
Related to this article
Povetacicept reduced proteinuria by 52% vs 4.3% with placebo at week 36 in adults with IgA nephropathy in the phase 3 RAINIER trial’s interim analysis.
At IDWeek 2026, IDSA and HIVMA leaders and clinician advocates outline how stories, relationships, and bipartisan outreach shape ID and HIV policy.
Speakers at ASN Kidney Week urge nephrologists to appeal prior authorization denials, include children in trials, and expand access to glomerular disease therapies globally.
Outpatient dialysis for unfunded patients with ESKD cut ED reliance and costs, while church-based CKD screening improved blood pressure.
At IDWeek 2026, Atul Gawande, MD, MPH, said USAID cuts are costing lives but that the field is "not back at square one."
Oncologists weighted how to choose, manage, and deliver new therapeutics beyond major academic centers.
As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for advanced kidney disease.
Advertisement
Advertisement